| dc.contributor.author | Jagtap, Rohidas | |
| dc.contributor.author | Thorat, S.H. | |
| dc.contributor.author | Gonnade, R.G. | |
| dc.contributor.author | Khan, A.K. | |
| dc.contributor.author | Pardeshi, Satish | |
| dc.date.accessioned | 2020-03-05T09:23:57Z | |
| dc.date.available | 2020-03-05T09:23:57Z | |
| dc.date.issued | 2017-12-05 | |
| dc.identifier.uri | https://pubs.rsc.org/en/content/articlelanding/2018/nj/c7nj02961f#!divAbstract | |
| dc.identifier.uri | http://hdl.handle.net/123456789/245 | |
| dc.description.abstract | Diastereomeric ‘2RS,4R’-2-arylthiazolidine-4-carboxylic acids (ATCAs) were synthesized and their resolution to chiraly pure N-BOC derivatives was attempted by column chromatography. The absolute stereochemistry of the resolved compounds was ascertained by X-ray single crystal structures. Further application of the synthesized compounds was studied for their in vitro anti-breast cancer activity against MCF7 cell line using DOX as a standard by MTT assay method. Cell morphology analysis was carried out by fluorescence microscopy. The compounds containing ‘2S’ absolute configuration in thiazolidine ring and presence of 2-NO2, 2,6-Cl groups on ‘2R’-aryl substituent showed significant anti-breast cancer activity where some of the compounds were found to be more active than DOX in terms of induced apoptosis mode of MCF7 cell death. | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | Royal Society of Chemistry's New Journal of Chemistry Issue 2, 2018 | en_US |
| dc.subject | CHEMISTRY | en_US |
| dc.subject | X-RAY CRYSTALS | en_US |
| dc.subject | ANTI BREAST CANCER PROPERTY | en_US |
| dc.subject | CARBOXYLIC ACIDS | en_US |
| dc.title | X-ray crystal structures and anti-breast cancer property of 3-tert-butoxycarbonyl-2-arylthiazolidine-4-carboxylic acids† | en_US |
| dc.type | Research Paper | en_US |